Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection

Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection

Infants with HIV infection are vulnerable to Pneumocystis carinii pneumonia (PCP) during their first year of life. WHO and the Joint United Nations Programme on HIV/AIDS now recommend that all children of HIV-positive mothers receive prophylactic cotrimoxazole against PCP from six weeks of age and c...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Gill Christopher J., Sabin Lora L., Tham Joseph, Hamer Davidson H.
Format: Artikel
Sprache:English
Veröffentlicht: The World Health Organization 2004-01-01
Schriftenreihe:Bulletin of the World Health Organization
Schlagworte:
Trimethoprim-sulfamethoxazole combination/therapeutic use
Trimethoprim-sulfamethoxazole combination/adverse effects
Pneumonia, Pneumocystis/drug therapy
HIV infections/complications
AIDS-related opportunistic infections/drug therapy
Disease transmission, Vertical
Drug resistance, Microbial
Sulfadoxine/pharmacology
Pyrimethamine/pharmacology
Infant
Risk assessment
Meta-analysis
Models
Theoretical
Africa
Online Zugang:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000400011

Online

http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862004000400011

Ähnliche Einträge